4SEPTEMBER - 2021TECH OUTLOOKThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientIN MY OPINIONNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]0820COVER STORY 12CXO INSIGHTSThe Future of Imaging and the Role of the Pathology Data Scientist in Drug DiscoveryJason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZenenca [LON:AZN]Eric Bolesh, COO
< Page 3 | Page 5 >